News

Filter

Algeta prepares for Alpharadin US launch, opening US base

19-09-2012

In anticipation of the launch of Alpharadin (radium-223 chloride), for the treatment of cancer patients…

AlgetaAlpharadinBayerMarkets & MarketingNorth AmericaOncologyPharmaceutical

Algeta takes up option to co-promote Alpharadin in the USA

13-04-2012

Norwegian cancer therapeutics developer Algeta ASA (OSE: ALGETA) says that it has exercised its option…

AlgetaAlpharadinBayerLicensingMarkets & MarketingOncologyPharmaceutical

Bayer and Algeta’s Alpharadin efficacy confirmed; Almirall to market Xarelto in Spain

13-02-2012

German drug major Bayer (BAY: DE) and Norwegian partner Algeta (OSE: ALGETA) announced that the survival…

AlgetaAlmirallAlpharadinBayerCardio-vascularEuropeMarkets & MarketingOncologyPharmaceuticalRegulationResearchXarelto

Bayer boasts four potential pipeline blockbusters

21-12-2011

German drugs and crop and material sciences group Bayer (BAT: DE) said yesterday that it plans to continue…

AlpharadinBayerCardio-vascularEyleaFinancialMarkets & MarketingOncologyOphthalmicsPharmaceuticalregorafenibResearchXarelto

Back to top